RASGRP1 and acute lymphoblastic leukemia: We previously reported that T-ALL patients with high RasGRP1 expression responded relatively well to treatment (S1B Fig and [6]) and also find that the lymphoblasts of patients in this dataset who failed induction therapy express higher expression of p110 β or δ isoforms (S1C Fig).